Results 201 to 210 of about 216,547 (314)

Demographic Change in Prevalent Type 1 Diabetes Adult Population, and Association of Risk Factors With Comorbidities and Mortality—Results From the Finnish Diabetes Control Study FinDiCon

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aims The objective was to characterise Finnish adults with type 1 diabetes (T1D) and to explore associations between known risk factors, comorbidities and mortality. Materials and Methods Individuals with T1D in 2014–2021 were identified from national health care registers, and data on medication and comorbidities were combined with laboratory
Hannu Vessari   +8 more
wiley   +1 more source

A Type 2 Diabetes Policy Model That Predicts Remaining Life Expectancy, Quality‐Adjusted Life Expectancy and Healthcare Costs for Use in Economic Evaluation, Incorporating Equity Concerns

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aims To illustrate a T2DM policy model incorporating socio‐economic status. Materials and Methods Using the Scottish Diabetes Research Network (SDRN) national diabetes cohort, we identified individuals newly diagnosed with T2DM between 1 January 2004 and 31 December 2020 and followed from diagnosis until death or end of follow‐up.
Lili Wei   +10 more
wiley   +1 more source

Cost‐Effectiveness of Automated Insulin Delivery Systems in Paediatrics, T1D and T2D Adults Across Four Nordic Countries

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aims This study evaluated long‐term cost‐effectiveness of automated insulin delivery (AID) systems versus multiple daily injections (MDI) + CGM in children with type 1 diabetes (T1D), adults with T1D and insulin‐treated individuals with type 2 diabetes (T2D) across Denmark, Finland, Norway and Sweden.
Johan Jendle   +5 more
wiley   +1 more source

Efficacy and Safety of Automated Insulin Delivery in People With Type 2 Diabetes: A Systematic Review and Meta‐Analysis

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aims Studies evaluating automated insulin delivery (AID) in type 2 diabetes are limited in number and often conducted in small cohorts. We aimed to summarize efficacy and safety data through a systematic review and meta‐analysis. Materials and Methods We searched MEDLINE, PubMed, Web of Science, and CENTRAL databases and performed hand ...
Sergio Di Molfetta   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy